Katherine Heigl may have exited Grey’s Anatomy in 2010, but that doesn’t mean she hasn’t retained some of the skills she learned. The Firefly Lane star, 46, shared the medical knowledge she ...

Casey Means’s time in the trenches, and her claim of willingness to sacrifice her own medical advancement in a corrupt system to fight for America’s health, have, in some corners of the ...

Tragedy has struck Nashville, Tennessee. Not really… unless you happen to be a ... Summer” singer was apparently stolen right off of a bench in Nashville’s Centennial Park. The plaque, which reads ...

Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN. (A.L.G., M.M.D., A.B.C., K.C.V., A.C.D.) Department of Medicine ...

The Nashville Edition hotel and residences officially ... Real Estate Partners CEO Mick Walsdorf in a news release. A sales center for the condominiums is now open to interested buyers at 1108 ...

Baylor Scott & White Medical Center—Centennial recently expanded their ... The above story was produced by Multi-platform Journalist Mary Katherine Shapiro with Community Impact's Storytelling ...

Tennessee in June 2019. An affidavit filed in federal court says posts made by Prater in several group chats affiliated with white supremacist groups link him to the Highlander Center fire.

CERo Therapeutics Holdings, Inc. has announced that TriStar Centennial Medical Center in Nashville, Tennessee, will serve as a clinical trial site for its Phase 1 clinical study of CER-1236 ...

announces that TriStar Centennial Medical Center, through Sarah Cannon Research Institute (SCRI), in Nashville, Tennessee, is a clinical trial site for the Company’s Phase 1 clinical of CER-1236.

announces that TriStar Centennial Medical Center, through Sarah Cannon Research Institute (SCRI), in Nashville, Tennessee, is a clinical trial site for the Company’s Phase 1 clinical of CER-1236.

announces that TriStar Centennial Medical Center, through Sarah Cannon Research Institute (SCRI), in Nashville, Tennessee, is a clinical trial site for the Company's Phase 1 clinical of CER-1236.